Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ETO interacting proteins.

Bruce A Hug1, Mitchell A Lazar

  • 1Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. brucehug@mail.med.upenn.edu

Oncogene
|May 25, 2004
PubMed
Summary

The 8;21 translocation creates the AML1-ETO fusion protein, altering myeloid transcription factor AML1. This fusion disrupts normal protein interactions, leading to altered coregulator recruitment and contributing to leukemia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondrial carrier SLC25A34 links clock, diet, and temperature control of interorganellar lipid cycling.

bioRxiv : the preprint server for biology·2026
Same author

Integrative analyses elucidate transcriptional regulatory functions of risk alleles for metabolic liver disease.

Nature genetics·2026
Same author

Reduction in Hepatic Phosphatidylcholine Biosynthesis Promotes MASH Through Copper Deficiency.

bioRxiv : the preprint server for biology·2026
Same author

Author Correction: Circadian circuits control plasticity of group 3 innate lymphoid cells by sustaining epigenetic configuration of RORγt.

Nature immunology·2026
Same author

CD9 regulates macrophage-mediated remodeling of adipose tissue in obesity.

JCI insight·2026
Same author

REV-ERB-alpha and -beta coordinately regulate astrocyte reactivity and proteostatic function.

Proceedings of the National Academy of Sciences of the United States of America·2026

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • The 8;21 chromosomal translocation is common in acute myeloid leukemia.
  • This translocation results in a fusion protein, AML1-ETO, which is oncogenic.
  • The AML1-ETO fusion protein differs structurally from wild-type AML1.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying the oncogenic activity of the AML1-ETO fusion protein.
  • To identify proteins that interact with the ETO portion of the AML1-ETO fusion.
  • To understand how altered protein interactions contribute to leukemogenesis.

Main Methods:

  • Biochemical analyses were performed to identify proteins interacting with ETO.
  • The study focused on the coregulator recruitment domains of AML1 and ETO.
  • Interactions with corepressors, including histone deacetylases (HDACs), were examined.

Main Results:

  • The AML1-ETO fusion protein primarily consists of the ETO protein's coregulator recruitment domains.
  • ETO interacts with a distinct set of proteins compared to wild-type AML1.
  • These interacting proteins include various corepressors, such as HDACs and components of HDAC core complexes.

Conclusions:

  • Altered coregulator recruitment by the AML1-ETO fusion protein is a key mechanism driving its oncogenic properties.
  • The specific interactions of ETO with corepressors provide mechanistic insight into leukemogenesis.
  • Understanding these interactions may offer therapeutic targets for AML.

Related Experiment Videos